Influenza Diagnostics Market Size, Share, Growth Analysis, By Test Type(Traditional Diagnostic Test, Molecular Diagnostic Assay), By End-User(Hospital, Laboratories, Other End Users), By Region - Industry Forecast 2024-2031

Influenza Diagnostics Market Driver

Growing Focus on Influenza Diagnostic Research 

• The rising global prevalence of influenza has surged the R&D activities for the accurate detection and diagnosis. Although the major concentration of research activities is targeted towards the development of a rapid and precise diagnosis of the influenza viruses, it will drive market growth as well. In addition to this, the rising incidences of government initiatives against the outbreak of influenza, technological advancements, and the increasing incidences of cardiovascular diseases and diabetes will provide a further push to market growth. 

Development in Genomic Technologies

• Many assays and technologies have been developed to diagnose and manage influenza infection because of the human genome project and the advances made in molecular and biomedical technologies. These technologies, which are mainly genomic such as PCR, and proteomics, such as microarray detection, are useful in the discovery of new types of influenza virus. In addition, they may help in surveillance and rapid diagnosis of an infectious disease, which is a market opportunity. 

Restraints 

Lack of Skilled Technicians  

• The lack of skilled and professional personal along with unstable regulatory framework of new diagnostic test approval will obstruct the market’s growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.  

Complexity of Influenza Virus 

• Influenza diagnostic tests are generally influenced by sensitivity and specificity which are a consequence of the antigenic variation by influenza viruses. Due to this factor, influenza diagnostic tests have varied sensitivity and specificity. Periods of high prevalence and circulation of influenza are associated with high levels of false-negative results which are more common than false-positive results, a factor that hinders the growth of the influenza diagnostics market.